Close Menu

University of Toronto

Researchers identified variants in the germline that appear to influence DNA methylation levels in prostate cancer tumors or in precancerous tissues.

In Nature this week: immunomagnetic method for sorting cells, cumulative effects of rare and common risk variants in schizophrenia, and more.

In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.

Push for Sequencing

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

An epigenome-wide association study of major psychosis uncovered hypomethylation at an enhancer that targets a gene involved in dopamine synthesis.

In PLOS this week: potential cystic fibrosis modifiers, potential kidney cancer survival signature, and more.

In PNAS this week: early-onset preeclampsia model, lateral gene transfer events in grasses, and more.

Researchers used exome capture RNA sequencing to come up with a collection of circRNAs in dozens of cancer types, including proposed prostate cancer markers.

The money is being provided under three Genome Canada funding competitions in partnership with the Canadian federal government and other groups.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.

Pages

Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.

University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.

NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.

In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.